ClinicalTrials.Veeva

Menu
C

Christian Medical College | Pulmonary Medicine

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Docetaxel
Capsaicin
Finerenone
Nintedanib
Milvexian
Doxorubicin
Eteplirsen
Bevacizumab
Tenofovir
Zidovudine

Parent organization

This site is a part of Christian Medical College

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 65 total trials

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian

This study will be comprised of 2 parts: Part 1 (dose escalation) will be conducted to evaluate the safety and tolerability of 2 doses (100 milligram...

Active, not recruiting
Muscular Dystrophy, Duchenne
Drug: Eteplirsen

Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys' ability to work pr...

Active, not recruiting
Chronic Kidney Disease
Type 2 Diabetes Mellitus
Drug: Finerenone (Kerendia, BAY94-8862)

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA...

Active, not recruiting
Immunoglobulin A Nephropathy
IgA Nephropathy
Drug: Placebo
Drug: Atrasentan

The study intends to show that basimglurant (NOE-101) provides effective seizure control in children, adolescents and young adults with Tuberous Scle...

Active, not recruiting
Tuberous Sclerosis Complex
Drug: Basimglurant with crossover to Placebo
Drug: Placebo with crossover to Basimglurant

Treatment with PF-06741086 is anticipated to demonstrate a clinically relevant advantage and/or a major contribution to patient care in comparison to...

Active, not recruiting
Hemophilia B
Hemophilia A
Drug: PF-06741086

Trial sponsors

C
Pfizer logo
S
Boehringer Ingelheim logo
I
O
U
F
Actelion Pharmaceuticals logo
Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems